Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00986141 · ClinicalTrials.gov registry record
Effects of Selective Laser Trabeculoplasty
A clinical trial, sponsored by University of Kentucky.
- Terminated
- Registry status
- 30
- Enrollment target
NCT00986141: Clinical Trial study, sponsored by University of Kentucky.
NCT00986141 is a clinical trial that was terminated before completion, run by University of Kentucky. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00986141 was terminated before completion, sponsored by University of Kentucky.
- TERMINATED
- Registry status
- 30 participants
- Enrollment target
Study Summary
Primary objective is to evaluate the effect of selective laser trabeculoplasty (SLT) on the diurnal intraocular pressure variation in open-angle glaucoma patients (OAG).
Interventions
- PROCEDURE Surgery
- PROCEDURE Selective Laser Trabeculoplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-12 |
Why NCT00986141 stopped before completion
NCT00986141 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Surgery is the first listed.
NCT00986141 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00986141 about?
NCT00986141 is a clinical study titled "Effects of Selective Laser Trabeculoplasty". Primary objective is to evaluate the effect of selective laser trabeculoplasty (SLT) on the diurnal intraocular pressure variation in open-angle glaucoma patients (OAG).
What is the current status of trial NCT00986141?
This trial is currently terminated. The enrollment target is 30 participants. The study started on 2009-05. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00986141?
The interventions under investigation include: Surgery (PROCEDURE), Selective Laser Trabeculoplasty (PROCEDURE).
Who is sponsoring clinical trial NCT00986141?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia